Back

Beta-blockers in non-ST elevation acute coronary syndrome and preserved left ventricular ejection fraction: is there long term benefit?

9 December 2017 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster session 6 - Ischemic heart disease Myocardial ischemia EACVI Premium Access EuroEcho-Imaging 2017

About the speaker

Photo
Doctor Joel Ponte Monteiro

Hospital Dr. Nelio Mendonca, Funchal (Portugal)

4 More presentations in this session

Presentation thumbnail
Doctor R. Alieva (Tashkent, UZ)
Abstract
Presentation thumbnail
Doctor A. Khilchuk (Saint Petersburg, RU)
Abstract Slides
Presentation thumbnail
Professor V. Kuznetsov (Tyumen, RU)
Presentation thumbnail
Doctor K. Wdowiak-Okrojek (Lodz, PL)
Abstract

Access the full session

Session thumbnail
Poster session 6 - Ischemic heart disease

The Event

Event poster

EuroEcho-Imaging 2017

9 December 2017 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Long-term beta-blocker therapy after revascularised acute coronary syndrome (ACS) with preserved ejection fraction: a multi-centre retrospective cohort study
31 August 2026
thumbnail
Congress Presentation
Echocardiographically determined ejection fraction in the elderly admitted with non-ST-elevation acute coronary syndromes in a spoke hospital with no cath-lab facility and the treatment-risk paradox
9 December 2021
thumbnail
Congress Presentation
Do beta-blockers increase the risk for hospitalizations in heart failure with preserved ejection fraction? a secondary analysis of beta-blocker use in the TOPCAT trial
1 September 2019
thumbnail
Congress Presentation
Long-term benefit of vasodilating beta-blocker in patients with mildly reduced left ventricular systolic function after acute myocardial infarction
20 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources